SFDA approves registration of 'Tzield' for delaying type1 diabetes

About Me

Senbookpro KAAYXOL

Related News

News Home » Browse News » SFDA approves registration of 'Tzield' for delaying type1 diabetes

Posted by - Senbookpro KAAYXOL -

on - 4 hours ago -

Filed in - Arts & Culture -

3 Views - 0 Comments - 0 Likes - 0 Reviews

Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has approved the registration of Tzield (teplizumab) to delay the onset of Stage 3 type 1 diabetes in adults and pediatric patients

Read Full News Here

Photos

Photos

0 albums found

Senbookpro

At our community we believe in the power of connections. Our platform is more than just a social networking site; it's a vibrant community where individuals from diverse backgrounds come together to share, connect, and thrive.
We are dedicated to fostering creativity, building strong communities, and raising awareness on a global scale.

Explore

Quick Links

About Us

KAAYXOL
support@kaayxol.ma
+212627 492068